T. G. Mcginn, G. H. Guyatt, P. C. Wyer, C. D. Naylor, I. G. Stiell et al., Users guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group, JAMA, vol.284, pp.79-84, 2000.

F. Pene, C. Rieux, C. Pantas, R. Horchani, H. Rafi et al., Prise en charge des neutropénies fébriles à haut risque en hématologie: Infections en Hématologie, pp.9-34, 2001.

B. De-pauw, T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards et al., Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis, vol.46, pp.1813-1834, 2008.

E. Castagnola, V. Fontana, I. Caviglia, S. Caruso, M. Faraci et al., A prospective study on the epidemiology of febrile episodes during chemotherapy induced neutropenia in children with cancer or after hemopoietic stem cell transplantation, Clin Infect Dis, vol.45, pp.1296-304, 2007.

B. E. Werba, W. Hobbie, A. E. Kazak, R. F. Ittenbach, A. F. Reilly et al., Classifying the intensity of pediatric cancer treatment protocols: the intencity of treatment rating scale 2.0 (ITR-2), REFERENCES 1, vol.48, pp.749-57, 1990.

K. 2-pritchard-jonesa, P. Kaatschb, E. Steliarova-foucherc, C. A. Stillerd, and J. Coeberghe, Cancer in children and adolescents in Europe:Developments over 20 years and future challenges, Eur J Cancer, vol.42, pp.2183-90, 2006.

G. Gatta, L. Botta, S. Rossi, T. Aareleid, M. Bielska-lasota et al., 4-Orbach D, Chastagner P, Doz F. Cancer in children: epidemiologic, diagnostic and therapeutic characteristics, Lancet Oncol, vol.15, pp.557-63, 2008.

F. Crokaert, Febrile neutropenia in children, Int J Antimicrob Agents, vol.16, pp.173-179, 2000.

P. A. 6-pizzo, Management of fever in patients with cancer and treatment-induced neutropenia, N Engl J Med, vol.328, pp.1323-1355, 1993.

E. P. Baorto, V. M. Aquino, C. A. Mullen, G. R. Buchanan, M. Debaun et al., Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group, REFERENCES 1, vol.92, pp.79-84, 2000.

I. G. Stiell and G. A. Wells, Methodologic standards for the development of clinical decision rules in emergency medicine, Ann Emerg Med, vol.33, pp.437-484, 1999.

J. L. Maguire, D. M. Kulik, A. Laupacis, N. Kuppermann, E. M. Uleryk et al., Clinical prediction rules for children: a systematic review, Pediatrics, vol.128, pp.666-77, 2011.

D. Moher, A. Liberati, J. Tetzlaff, D. Altman, and . Group, Preferred reporting items for systematic REFERENCES

M. Delebarre, F. Dubos, E. Macher, N. Garnier, D. Berranger et al., Identifying high-risk patients for severe infection in children with chemotherapy-induced febrile neutropenia: a new decision rule, Congrès SIOP, 2010.

M. Delebarre, F. Dubos, P. Leblond, and F. Mazingue, Distinction des neutropénies fébriles post-chimiothérapie à risque d'infection sévère: projet d'étude prospective multicentrique. Congrés SFCE, séance plénière, 2011.

F. Pene, C. Rieux, C. Pantas, R. Horchani, H. Rafi et al., Prise en charge des neutropénies fébriles à haut risque en hématologie: Infections en Hématologie, pp.9-34, 2001.

R. Rakotomalala, Arbres de Décision. Revue MODULAD, vol.33, pp.163-87, 2005.

M. E. Santolaya, A. W. Alvarez, C. L. Avoles, A. Becker, J. Cofre et al., Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutopenia, Clin Infect Dis, vol.35, pp.678-83, 2002.

J. L. Maguire, D. M. Kulik, A. Laupacis, N. Kuppermann, E. M. Uleryk et al., Clinical prediction rules for children: a systematic review, Pediatrics, vol.128, pp.666-77, 2011.

P. I. Rondinelli, C. Ribeiro-k-de, and B. De-camargo, A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia, J Pediatr Hematol Oncol, vol.28, pp.665-70, 2006.

R. A. Ammann, A. Hirt, A. R. Lüthy, and C. Aebi, Identification of children presenting with fever in chemotherapyinduced neutropenia at low risk for severe bacterial infection, Med Pediatr Oncol, vol.41, pp.436-479, 2003.

I. G. Stiell and G. A. Wells, Methodologic standards for the development of clinical decision rules in emergency medicine, Ann Emerg Med, vol.33, pp.437-484, 1999.

M. E. Santolaya, A. M. Alvarez, C. L. Avilés, A. Becker, J. Cofré et al., Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection, J Clin Oncol, vol.22, pp.3784-3793, 2004.

C. Oude-nijhuis, W. A. Kamps, S. M. Daenen, J. A. Gietema, W. T. Van-der-graaf et al., Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients, Clin Oncol, vol.23, pp.7437-7481, 2005.

E. A. Loeffen, T. Poele, E. M. Tissing, W. J. Boezen, H. M. De-bont et al., Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia, Cochrane Database Syst Rev, vol.2, p.8382, 2016.

P. D. Robinson, T. Lehrnbecher, R. Phillips, L. L. Dupuis, and L. Sung, Strategies for empiric management of pediatric fever and neutropenia in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review of randomized trials, J Clin Oncol, vol.34, pp.2054-60, 2016.

S. Cheng, O. Teuffel, M. C. Ethier, C. Diorio, J. Martino et al., Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia, Br J Cancer, pp.23-606, 2011.

D. W. Raisch, M. T. Holdsworth, S. S. Winter, J. J. Hutter, and M. L. Graham, Economic comparison of home-carebased versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children, Value Health, 2003.

J. L. Maguire, D. M. Kulik, A. Laupacis, N. Kuppermann, E. M. Uleryk et al., Clinical prediction rules for children: a systematic review, Pediatrics, vol.128, pp.666-77, 2011.

M. Delebarre, N. Garnier, E. Macher, E. Thebaud, F. Mazingue et al., Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?, J Pediatr Hematol Oncol, vol.37, pp.468-74, 2015.

T. G. Mcginn, G. H. Guyatt, P. C. Wyer, C. D. Naylor, I. G. Stiell et al., Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group, JAMA, vol.284, pp.79-84, 2000.

B. Goldstein, B. Giroir, and A. Randolph, and the members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics, Pediatr Crit Care Med, pp.6-8, 2005.

T. Lehrnbecher, R. Phillips, A. S. Alvaro, F. Carlesse, F. Fisher et al., Guideline for the management of fever and neutropenia in childrenwith cancer and/or undergoing hematopoietic stem-cell transplantation, J Clin Oncol, vol.30, pp.4427-4465, 2012.

P. D. Robinson, T. Lehrnbecher, R. Phillips, L. L. Dupuis, and L. Sung, Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials, J Clin Oncol, vol.34, pp.2054-60, 2016.

E. P. Baorto, V. M. Aquino, C. A. Mullen, G. R. Buchanan, and M. R. Debaun, Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia, Cancer, vol.92, pp.909-922, 2001.
DOI : 10.1002/1097-0142(20010815)92:4<909::aid-cncr1400>3.0.co;2-h
URL : http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(20010815)92:4<909::AID-CNCR1400>3.0.CO;2-H/pdf

. Dommett-r-1, J. Geary, S. Freeman, J. Hartley, M. Sharland et al., Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting, Eur J Cancer, vol.45, pp.2843-2852, 2009.

R. A. Ammann, N. Bodmer, A. Hirt, F. K. Niggli, D. Nadal et al., Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study, J Clin Oncol, vol.28, pp.2008-2022, 2010.
DOI : 10.1200/jco.2009.25.8988

G. S. Collins, E. O. Ogundimu, and D. G. Altman, Sample size considerations for the external validation of a multivariable prognostic model: aresampling study, Stat Med, vol.35, pp.214-240, 2016.

E. Macher, F. Dubos, N. Garnier, M. Delebarre, D. Berranger et al., Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia: reproducibility and validity of six clinical decision rules, Pediatr Blood Cancer, vol.55, pp.662-669, 2010.

M. E. Santolaya, A. M. Alvarez, C. L. Avilés, A. Becker, J. Cofré et al., Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever and neutropenia, Clin Infect Dis, vol.35, pp.678-83, 2002.

M. Delebarre, E. Macher, A. Martinot, and F. Dubos, Which decision rules follow methodological standards in children with febrile neutropenia? Results of a systematic methodological review and analysis, Pediatric Blood and Cancer, vol.61, pp.1786-91, 2014.

K. G. Miedema, E. S. De-bont, O. Nijhuis, C. S. Van-vliet, D. Kamps et al., Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia, J Clin Oncol, vol.29, pp.182-184, 2011.

C. Oude-nijhuis, W. A. Kamps, S. M. Daenen, J. A. Gietema, W. T. Van-der-graaf et al., de Vries-Hospers HG, de Bont ES.J Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients, Clin Oncol, vol.23, pp.7437-7481, 2005.

R. S. Phillips, R. Wade, T. Lehrnbecher, L. A. Stewart, and A. J. Sutton, Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer, BMC Med, vol.10, p.6, 2012.

G. M. Haeusler, F. Carlesse, R. Phillips, S. Livadiotti, G. M. Milano et al., An updated systematic review and meta-analysis of the predictive value of serumbiomarkers in the assessment of fever during neutropenia in children with cancer, REFERENCES 1, vol.32, pp.147-50, 2012.

M. Boragina, H. Patel, S. Reiter, and G. Dougherty, Management of febrile neutropenia in pediatric oncology patients: a Canadian survey, Pediatr Blood Cancer, vol.48, pp.521-527, 2007.

B. Phillips, K. Selwood, S. M. Lane, R. Skinner, F. Gibson et al., Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres, Arch Dis Child, vol.92, pp.495-503, 2007.

J. D. Chamberlain, E. Smibert, J. Skeen, and F. Alvaro, Prospective audit of treatment of paediatric febrile neutropenia in Australasia, J Paediatr Child Health, vol.41, pp.598-603, 2005.

G. M. Haeusler, R. S. Phillips, T. Lehrnbecher, K. A. Thursky, L. Sung et al., Core outcomes and definitions for pediatric fever and neutropenia research: a sonsensus statement from an international panel, Pediatr Blood Cancer, vol.62, pp.483-489, 2015.
DOI : 10.1002/pbc.25335

E. L. Mueller, K. J. Walkovich, G. A. Yanik, and S. J. Clark, Variation in management of fever and neutropenia among pediatric patients with cancer: a survey of providers in Michigan, Pediatr Hematol Oncol, vol.32, pp.331-371, 2015.

E. Macher, F. Dubos, N. Garnier, M. Delebarre, D. Berranger et al., International pediatric fever and neutropenia guideline panel. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation, Pediatr Blood Cancer, vol.55, issue.9, pp.4427-4465, 2010.

, une prise en charge avec une sortie précoce avec un relais de l'antibiothérapie orale ou d'une prise en charge à domicile avec une antibiothérapie intraveineuse que dans le cadre d'une hospitalisation ou d'une prise en charge à domicile avec une antibiothérapie orale, vol.15

, Quelle que soit le type d'allègement envisagé il est important de noter que la RDC est un

, En effet certains facteurs notamment sociaux peuvent rendre cet allègement inapplicable, même si l'enfant est classé à bas risque. Le niveau de compréhension parental, la surveillance, la réévaluation, ainsi que les conditions de vie sont des éléments importants devant être pris en compte dans la décision

T. G. Références-1-mcginn, G. H. Guyatt, P. C. Wyer, C. D. Naylor, I. G. Stiell et al., Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group, JAMA, vol.284, pp.79-84, 2000.

A. Laupacis, N. Sekar, and I. G. Stiell, Clinical prediction rules. A review and suggested modifications of methodological standards, JAMA, vol.277, pp.488-94, 1997.

I. G. Stiell and G. A. Wells, Methodologic standards for the development of clinical decision rules in emergency medicine, Ann Emerg Med, vol.33, pp.437-447, 1999.

T. Lehrnbecher, R. Phillips, A. S. Alvaro, F. Carlesse, F. Fisher et al., International pediatric fever and neutropenia guideline panel. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation, J Clin Oncol, vol.30, pp.4427-4465, 2012.

E. Brack, N. Bodmer, A. Simon, K. Leibundgut, T. Kühne et al., First-day stepdown to oral outpatient treatment versus continued standard treatment in children with cancer and lowrisk fever in neutropenia

, Pediatr Blood Cancer, vol.59, pp.423-453, 2012.

O. Teuffel, S. Cheng, M. C. Ethier, C. Diorio, J. Martino et al., Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients, Support Care Cancer, vol.20, pp.2755-64, 2012.

A. F. Klassen, P. Raina, C. Mcintosh, L. Sung, R. J. Klaassen et al., Parents of children with cancer: which factors explain differences in health-related quality of life, Int J Cancer, vol.129, pp.1190-1198, 2011.

L. Sung, B. M. Feldman, G. Schwamborn, D. Paczesny, A. Cochrane et al., Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences, J Clin Oncol, vol.22, pp.3922-3931, 2004.

L. Sung, S. M. Alibhai, M. C. Ethier, O. Teuffel, S. Cheng et al.,

, J Clin Epidemiol, vol.65, pp.627-661, 2012.

O. Teuffel, E. Amir, S. Alibhai, J. Beyene, and L. Sung, Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients, Br J Cancer, vol.104, pp.1377-83, 2011.

D. Cataudella, T. E. Morley, A. Nesin, C. V. Fernandez, D. L. Johnston et al., Development of a quality of life instrument for children with advanced cancer: the pediatric advanced care quality of life scale (PAC-QoL), Pediatr Blood Cancer, vol.61, pp.1840-1845, 2014.

R. Gavidia, S. L. Fuentes, R. Vasquez, M. Bonilla, M. C. Ethier et al., Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador, PLoS One, vol.7, p.43639, 2012.

, Enregistrement du protocole initié dans le registre clinicaltrials.gov, sous la référence : Protocole ID suivante 2011_40